Abstract
The alterations of sexual function known as the erectile dysfunction are quite frequent among patients affected by liver diseases and they tend to increase in advanced liver failure. This process is directly linked to cirrhosis or its treatments, such as liver transplantation, or to certain drugs (e.g. beta-blockers). Independent of cirrhosis, other factors may cause sexual problems in these patients. Alcohol itself seems to worsen sexual function in the absence of cirrhosis. Viral hepatitis has an uncertain influence on male gonadic function and even antiviral therapy itself can worsen some seminal and hormonal parameters, although it is reversible. Quality of life may be greatly decreased in cases of cirrhosis where these alterations are present, so it is important to value and care for them, if possible. This review investigates the major male sexual disturbances in liver diseases of various origins.
Similar content being viewed by others
References
NIH Consensus Conference: Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993, 270: 83–90.
Toda K, Miwa Y, Kuriyama S, et al. Erectile dysfunction in patients with chronic liver disease: its relevance to protein malnutrition. J Gastroenterol 2005, 40: 894–900.
Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999, 281: 537–44.
Parazzini F, Menchini Fabris F, Bortolotti A, et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol 2000, 37: 43–9.
Cornely CM, Schade RR, Van Thiel DH, Gavaler JS. Chronic advanced liver disease and impotence: cause and effect? Hepatology 1984, 4: 1227–30.
Jensen SB, Gluud C. Sexual dysfunction in men with alcoholic liver cirrhosis. A comparative study. Liver 1985, 5: 94–100.
Wang YJ, Wu JC, Lee SD, Tsai YT, Lo KJ. Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men. Hepatogastroenterology 1991, 38: 531–4.
Simsek I, Aslan G, Akarsu M, Koseoglu H, Esen A. Assessment of sexual functions in patients with chronic liver disease. Int J Impot Res 2005, 17: 343–5.
Huyghe E, Kamar N, Wagner F, et al. Erectile dysfunction in end-stage liver disease men. J Sex Med 2009, 6: 1395–401.
Wetterling T, Veltrup C, Driessen M, John U. Drinking pattern and alcohol-related medical disorders. Alcohol Alcohol 1999, 34: 330–6.
Ronis MJJ, Wands JR, Badger TM, de la Monte SM, Lang CH, Calissendorff J. Alcohol-induced disruption of endocrine signaling. Alcohol Clin Exper Res 2007, 31: 1269–85.
Purohit V. Can alcohol promote aromatization of androgens to estrogens? A review. Alcohol 2000, 22: 123–7.
Soykan A, Boztas H, Idilman R, et al. Sexual dysfunctions in HCV patients and its correlations with psychological and biological variables. Int J Impot Res 2005, 17: 175–9.
Ferri C, Bertozzi MA, Zignego AL Erectile dysfunction and hepatitis C virus infection. JAMA 2002, 288: 698–9.
Danoff A, Khan O, Wan DW, et al. Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life. Am J Gastroenterol 2006, 101: 1235–43.
Gluud C, Wantzin P, Eriksen J. No effect of oral testosterone treatment on sexual dysfunction in alcoholic cirrhotic men. Gastroenterology 1988, 95: 1582–7.
Van Thiel DH, Gavaler JS, Sanghvi AJIT. Recovery of sexual function in abstinent alcoholic men. Gastroenterology 1982, 84: 677–82.
Lonardo A, Carani C, Carulli N, Loria P. ‘Endocrine NAFLD’ a hormonocentric perspective of non-alcoholic fatty liver disease pathogenesis. J Hepatol 2006, 44: 1196–207.
Villanova N, Moscatiello S, Ramilli S, et al. Endothelial dysfunction and cardiovascular risk profile in non-alcoholic fatty liver disease. Hepatology 2005, 42: 473–80.
Huang JM, Huang TH, Qiu HY, et al. Effects of hepatitis B virus infection on human sperm chromosomes. World J Gastronterol 2003, 9: 736–40.
Collodel G, Baccetti B, Capitani S, Moretti E. Necrosis in human spermatozoa. I. Ultrastructural features and FISH study in semen from patients with uro-genital infections. J Submicrosc Cytol Pathol 2005, 37: 67–73.
Heathcote J, Cameron CH, Dane DS. Hepatitis-B antigen in saliva and semen. Lancet 1974, 1: 71–3.
Qian WP, Tan YQ, Chen Y, et al. Rapid quantification of semen hepatitis B virus DNA by real-time polymerase chain reaction. World J Gastroenterol 2005, 11: 5385–9.
Hadchouel M, Scotto J, Huret JL, et al. Presence of HBV DNA in spermatozoa: a possible vertical transmission of HBV via the germ line. J Med Virol 1985, 16: 61–6.
Leruez-Ville M, Kunstmann JM, De Almeida M, Rouzioux C, Chaix ML. Detection of hepatitis C virus in the semen of infected men. Lancet 2000, 356: 42–3.
Levy R, Tardy JC, Bourlet T, et al. Transmission risk of hepatitis C virus in assisted reproductive techniques. Hum Reprod 2000, 15: 810–6.
Durazzo M, Premoli A, Di Bisceglie C, et al. Alterations of seminal and hormonal parameters: an extrahepatic manifestation of HCV infection? World J Gastroenterol 2006, 12: 3073–6.
Moretti E, Federico MG, Giannerini V, Collodel G. Sperm ultrastructure and meiotic segregation in a group of patients with chronic hepatitis B and C. Andrologia 2008, 40: 173–8.
Levy R, Bourlet T, Maertens A, et al. Pregnancy after safe IVF with hepatitis C virus RNA-positive sperm. Hum Reprod 2002, 17: 2650–3.
Garrido N, Meseguer M, Remohí J, Simón C, Pellicer A. Semen characteristics in human immunodeficiency virus (HIV)- and hepatitis C (HCV)-seropositive males: predictors of the success of viral removal after sperm washing. Hum Reprod 2005, 20: 1028–34.
Barton JC, Acton RT, Leiendecker-Foster C, et al; Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS Study initial screening. Am J Hematol 2008, 83: 126–32.
Tarnacka B, Rodo M, Cichy S, Członkowska A. Procreation ability in Wilson’s disease. Acta Neurol Scand 2000, 101: 395–8.
Soto Alvarez J, Sacristan JA, Alsar MJ. Interferon alfa-2a-induced impotence. Ann Pharmacother 1991, 25: 1397.
Kraus MR, Schäfer A, Bentink T, et al. Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: interferon-induced functional androgen deficiency or depression? J Endocrinol 2005, 185: 345–52.
Kartal ED, Alpat SN, Ozgunes I, Usluer G. Adverse effects of high-dose interferon-alpha-2a treatment for chronic hepatitis B. Adv Ther 2007, 24: 963–71.
Dove LM, Rosen RC, Ramcharran D, et al; Virahep-C Study Group. Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C. Gastroenterology 2009, 137: 873–84.
Sorrell JH, Brown JR. Sexual functioning in patients with end-stage liver disease before and after transplantation. Liver Transpl 2006, 12: 1473–7.
Foresta C, Schipilliti M, Ciarleglio FA, Lenzi A, D’Amico D. Male hypogonadism in cirrhosis and after liver transplantation. J Endocrinol Invest 2008, 31: 470–8.
Burra P. Sexual dysfunction after liver transplantation. Liver Transpl 2009, 15: S50–6.
Forgue ST, Phillips DL, Bedding AW, et al. Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics. Br J Clin Pharmacol 2007, 63: 24–35.
Nolte W, Schindler CG, Figulla HR, et al. Increase of serum estradiol in cirrhotic men treated by transjugular intrahepatic portosystemic stent shunt. J Hepatol 2001, 34: 818–24.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Durazzo, M., Premoli, A., Di Bisceglie, C. et al. Male sexual disturbances in liver diseases: What do we know?. J Endocrinol Invest 33, 501–505 (2010). https://doi.org/10.1007/BF03346632
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346632